Terisom 50 mg Sterile, Powder for dispersion for infusion
PDF Leaflet Revision Date: 19 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Empirical treatment of presumed fungal infection and severe systemic mycoses.
Dosage (summary)
3-6 mg/kg/day depending on indication; no adjustment for elderly.
Onset of Action / Duration
Onset: 30-60 mins, Duration: variable
Special Populations
- Renal impairment
- Elderly
- Paediatric patients
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Nephrotoxic medications
- Corticosteroids
- Digitalis glycosides
Contraindications
- Hypersensitivity to amphotericin B
Common side effects
- Fever
- Chills
- Hypokalaemia
- Nausea
- Vomiting
Counselling Points
- Monitor for infusion reactions
- Stay hydrated
- Report any severe side effects
Serious warnings
- Anaphylaxis
- Renal toxicity
- Severe infusion-related reactions
Important Disclaimer
The Terisom 50 mg Sterile, Powder for dispersion for infusion professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
